MAPT and Alzheimer disease: The phosphorylation stoichiometry of Tau in pathological aggregates is approximately three times higher than that of the physiological, soluble form of Tau (93), and this hyperphosphorylation is believed to be a critical step in the pathogenesis of AD (94).